SIU School of Medicine receives major gift for Alzheimer's research
A major gift to Southern Illinois University School of Medicine will transform the health care of people throughout Illinois and beyond. Dale and Deborah Smith recently donated a substantial financial
New study looks at use of Riluzole to slow Alzheimer's progression
Riluzole is an FDA-approved drug, currently used to treat amyotrophic lateral sclerosis (ALS; Lou Gehrig's disease) and is currently in a Phase II clinical trial for the treatment of mild Alzheimer’s
Dementia and Driving
According to the National Institute on Aging, there are more than 41 million licensed drivers age 65 and older on the roads, up from 26 million just 20 years ago. As a person ages, changes in health
SIU Medicine Group to Study COVID’s Potential Effects on Alzheimer’s
Medical researchers at SIU School of Medicine’s Neuroscience Institute are studying how the novel coronavirus may accelerate the progression of Alzheimer’s disease. Their data could help identify
The Center for Alzheimer's Disease and Related Disorders at SIU Medicine received a grant from the King’s Daughters Organization for the fourth year in a row
The King’s Daughters Organization awarded the Center for Alzheimer’s Disease and Related Disorders (CADRD) a grant for $7,724 to support our Minds in Motion and Opening Minds Through Art (OMA) Beyond
Alzheimer's researchers note cause of Alzheimer's to be multifaceted in new article
In August 2020, Erin Hascup PhD, Alzheimer's Center Director, and Kevin Hascup PhD, Assistant Professor published "Toward refining Alzheimer's disease into overlapping subgroups." The topic of the
Hascup named director of Alzheimer's center
Erin Hascup, PhD , has been named as the new director of the SIU Center for Alzheimer’s Disease and Related Disorders (CADRD) beginning January 1, 2020. Tom Ala, MD, was serving as the interim
Center for Alzheimer’s Disease ‘Steps Up’ in Spite of Budget Woes
Written by Lauren Murphy | Photos by Jason Johnson Published in Aspect s magazine, Autumn 2017 (40-4) As American lifespans increase due to progress on other medical frontiers, the toll from Alzheimer
Study May Offer Clues to Alzheimer's Progression
As American lifespans increase due to progress made on other medical frontiers, the toll from Alzheimer’s disease (AD) grows. More than 5 million Americans are living with the disease, and by 2050